Portal Log-in
Contact Us
Products
Products
The MAD7™ Nuclease
Onyx Instrument
Onyx Kits
Onyx Assays
Iterative Editing
Engineering Portal
Applications
Applications
Genome Discovery
Genome Discovery
Salt Stress
Adaptive Laboratory Evolution
Essential Gene Discovery
Forward Engineering
Forward Engineering
BMI Tolerance
Lysine Metabolic Engineering
Protein Engineering
Protein Production
Iterative Strain Improvement
Stress Tolerance
Resources & Support
Resources & Support
News & Events
Videos & Webinars
Documentation
Documentation
Literature
Technical documents
FAQ
Safety Data Sheets
Blog
Technology
Technology
Genome Editing
History of CRISPR
How does CRISPR work?
Digital Genome Engineering
Biosecurity
About Us
About Us
Careers
Leadership
Job Listings
Portal Log-in
Contact Us
The Inscripta
®
Blog
Subscribe
Genome-scale engineering
Digital genome engineering
Target discovery
Pathway engineering
Heterologous models
Biosecurity
Bioeconomy
Employee Spotlight
MAD7
Iterative Genome Engineering
May 17, 2022
Aldevron Licenses the Manufacturing of MAD7™ Nuclease from Inscripta
A partnership between two CRISPR pioneers will provide the global scientific community with GMP and RUO MAD7 Nuclease
Read More
December 21, 2021
Inscripta’s MAD7™ CRISPR Nucleases Helping Hudson River Biosciences Improve Plant Editing
In a recent webinar, Ben Mijts of Inscripta, and Gabino Sanchez of Hudson River Biotechnology, demonstrate how Inscripta’s MADzyme™ family of…
Read More
November 16, 2021
Expanding the gene editing toolbox for Bacillus subtilis with the MAD7™ nuclease
A review article
“
The CRISPR toolbox for the gram-positive model bacterium Bacillus subtilis” published last month in Critical Reviews in…
Read More
August 24, 2021
In New Publications, Scientists Report Use of MAD7™ Nuclease for Plant Editing and More
A key part of Inscripta’s mission is making genome engineering more accessible. To that end, we released the MAD7™ nuclease sequence for…
Read More
July 27, 2021
Heterologous Protein Optimization with Inscripta’s Onyx Workflow
Optimization of protein function and expression is important for academic research as well as industrial applications. Historically,…
Read More
March 9, 2021
Scientists Deploy the MAD7™ Nuclease for Mammalian Genome Edits
Even before we launched our benchtop Onyx™ platform for automated genome engineering, the Inscripta team had already made progress in addressing…
Read More
December 15, 2020
University of Edinburgh Scientists Demonstrate Value of Open-Source MAD7™ Enzyme
Here at Inscripta, our vision for expanding access to digital genome engineering has always been broader than developing an automated benchtop…
Read More